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1. INTRODUCTION 
The current understanding of the molecular basis 
of insulin action is rather limited despite the im- 
pressive effort made by several aboratories to elu- 
cidate the mechanisms of action of this hormone 
(l-31. However, the first step in insulin action is 
accepted to be binding of the hormone to cell- 
surface membrane components termed insulin re- 
ceptors [4]. Several new techniques have allowed us 
to define the structural features of the insulin receptor 
[5-121. In brief, the insulin receptor is an integral 
membrane glycoprotein, and has been found, in all 
tissues tudied thus far, to be composed of 2 major 
subunits (a respectively /3) of - 135 000 and 
- 95 000 M, respectively. All subunits are linked 
together by disulfide bridges into a large receptor 
complex of app. M, 350 000. Both the (Y- (M, 
135 000) and the P-subunit (M, 95 000) are glyco- 
proteins. Further, we have shown that both subunits 
of the insulin receptor are specifically precipitated 
with autoantibodies against insulin receptor [9- 121. 
The observation that the entire spectrum of meta- 
bolic effects (both acute and late) of insulin can be 
initiated by the interaction of ligands other than 
insulin (i.e., autoantibodies to insulin receptor) with 
the receptor has been taken as evidence that the 
receptor contains all the necessary information, 
and/or might be the ‘second messenger’ for insulin 
action (13,141. Further, information has been 
gathered suggesting that insulin action results in 
phosphorylation-dephosphorylation reactions in 
some cellular proteins 131. 
Thus an important question arises as to whether 
the receptor itself possesses an enzymatic activity 
leading to phosphorylation-dephosphorylation, or
is a substrate for such enzymatic activity. In intact 
rat hepatoma cells and cultured human IM-9 
lymphocytes insulin increases the phosphorylation 
of its own M, = 95 000 receptor subunit [ 151. 
Here, we have investigated the phosphorylation 
of the insulin receptor in normal rat hepatocytes, 
which are major target cells for insulin’s actions. We 
demonstrate in intact hepatocytes that insulin 
specifically stimulates the phosphorylation of its 
M, 95 000 receptor subunit. More importantly, 
we present the first demonstration of this insulin- 
induced covalent modification of its receptor sub- 
unit in a cell-free system. 
2. MATERIALS AND METHODS 
Abbreviations: SDS, sodium dodecyl sulfate; PAGE, 
polyacrylamide gel electrophoresis; M,, relative mol- 
ecular mass; EGF, epidermal growth factor; TIU, trypsin 
inhibitor unit 
Porcine insulin (monocomponent) was pur- 
chased from Novo (Copenhagen); epidermal growth 
factor was from Collab. Res.; Nonidet P-40, Triton 
x-100, phenylmethylsulfonyl fluoride, N- 
acetyl-D-glucosamine, wheat germ agglutinin- 
agarose, collagenase (type I), bovine serum albu- 
min (fraction V), and bacitracin were obtained from 
Sigma. Adenosine 5’-[y-‘LP]triphosphate, tetra 
(triethylammonium) salt (aqueous solution; 5000 
Ci/mmol) and [32P]orthophosphate (carrier-free, 
5000 Cilmmol) were obtained from the Radio- 
chemical Centre Amersham. All reagents for SDS- 
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PAGE were purchased from Biorad Lab. Serum 
from patient B2 with autoantibodies to insulin re- 
ceptor was a kind gift from Dr C.R. Kahn (Joslin 
Lab., Boston MA) [ 16- 181. 
2.1. Phosphorylation of intact hepatocytes 
Hepatocytes were isolated from male Wistar rats 
(150-200 g) by collagenase dissociation of the liver 
according to [ 191. After isolation, hepatocytes were 
washed twice in phosphate-free Krebs Ringer bi- 
carbonate medium enriched with bovine serum 
albumin (I%, w/v), bacitracin (0.8 mg/ml) and gen- 
tamycin (50 pg/ml). Three aliquots of cells (1.55 
2 X lo6 cells/ml) were gassed with 5% CC+95% 02 
and incubated in the presence of 32Pi (200 @/ml) 
for 30 min at 37°C. Afterwards, to one aliquot of 
cells, 10 -’ M insulin and to another aliquot, 5 x 
lo-’ M EGF were added, and the incubation 
continued for 5 min at 37°C. The reaction was 
stopped by addition of chilled buffer containing 
unlabeled phosphate (50 mM), NaF (100 mM), and 
EDTA (4 mM). The cells were washed twice in this 
solution, and extracted thereafter with Triton X- 100 
as in [lo]. Insulin receptors were purified 20-fold by 
chromatography of the cell extract on wheat germ 
agglutinin-agarose, and then specifically and 
quantitatively precipitated by autoantibodies to 
insulin receptor after addition of a second antibody 
[lo]. The immunoprecipitates were collected by 
centrifugation (10 000 x g, 5 min) and washed 
twice with cold Hepes buffer (50 mM). 
2.2. Phosphorylation procedure for solubilized 
insulin receptors 
Immediately after isolation, hepatocytes were 
washed twice with cold buffer containing Tris-HCl 
(20 mM) (pH 7.4), NaCl (50 mM), bacitracin 
(1 mM), Aprotinin (1000 TIU/ml) and soybean tryp- 
sin inhibitor (10 000 TIU/ml). The cells were col- 
lected by centrifugation, resuspended in the wash 
buffer containing Nonidet P-40 (0.5%) and deoxy- 
cholate (0.5%) and homogenized in a Dounce- 
homogenizer (140 strokes). Thereafter, the broken 
cells were solubilized for 90 min at 4°C by contin- 
uous stirring. This preparation was centrifuged at 
100 000 x g for 90 min at 4°C and the insoluble 
pellet was discarded. The supernatant was applied 
to a wheat germ agglutinin-agarose column, which 
was extensively washed at 4°C: desorption of 
bound glycoproteins was performed using N-acetyl- 
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glucosamine (0.3 M). This chromatography 
allows a 20-fold purification with nearly 100% 
recovery of the insulin receptor as determined by 
‘251-insulin binding [ 10,211. The two fractions. 
known to contain insulin receptors [ 10,2 11, were 
pooled and used in the phosphorylation experi- 
ments. 
For the phosphorylation of solubilized receptors 
a typical reaction mixture contained the following: 
solubilized insulin receptors (300 ~1); Hepes buffer 
(20 mM; pH 7.4); MnC12 (2 mM); 0.125% bovine 
serum albumin; [Y-~~P]ATP (0.1 PM); and, if 
present, insulin (10 - ’ M), EGF (5 x 10 ~ ’ M). 
The final volume was 325 ~1. The phosphoryla- 
tion reaction was initiated by the addition of 
[Y-~~P]ATP. The reaction tubes were incubated for 
5 min at 37°C. The reaction was terminated by 
addition of 65 ~1 ice-cold solution containing NaF 
and EDTA at final concentrations of 100 mM and 
10 mM, respectively. The insulin receptors were 
then quantitatively immunoprecipitated by a serum 
containing autoantibodies against insulin receptor 
as in [lo]. The immunoprecipitates were analyzed 
by SDS-PAGE. 
2.3. Gel electrophoresis and autoradiography 
The immunoprecipitates were boiled for 5 min in 
a solution containing SDS (3%.w/v), glycerol 
(lO%,v/v), sodium phosphate (10 mM), p-mercapto- 
ethanol (2%,v/v) and bromophenol blue (O.Ol%, 
w/v). Aliquots of the precipitates were analysed 
by one-dimensional SDS-PAGE according to 
[20] using a 5-15s linear gradient of acrylamide 
as a resolving gel. The gels were stained, dried, and 
autoradiographed as in [lo]. The autoradiograms 
were scanned in a microdensitometer (Gelman) for 
quantitative analysis. 
3. RESULTS 
3.1. Phosphorylation of insulin receptor in intact 
hepatocytes 
To investigate whether the insulin receptor can 
be phosphorylated in hepatocytes, cells were label- 
ed with 32Pi in the absence of insulin. When the 
solubilized labeled glycoproteins obtained from 
these cells were immunoprecipitated with auto- 
antibodies to receptor, a major labeled band was 
found with Mr 95 000 (fig. 1). This molecular species 
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a b C d 8 f To test the specificity of insulin’s effect, hepato- 
cytes were labeled with ’ 32Pi in the presence of 
EGF, which binds to its own receptor 1221 and phos- 
phorylates this receptor in hepatocytes [23]. The 
stimulating effect of insulin is specific, since 
EGF was without effect on labeling of the insulin 
receptor subunit (fig.1). 
3.2. Phosphorylation ofpurified insulin receptors 
In an attempt to localize the kinase activity res- 
ponsible for the phosphorylation of the receptor a 
preparation of soluble insulin receptors was incu- 
bated with [Y-~~P]ATP in the absence or presence of 
insulin (10 - 7 M). As observed with intact cells, 
insulin stimulated the phosphorylation of its own 
receptor subunit with M, 95 000 (fig.2). However, 
Fig. 1. Phosphorylation of M, 95 000 insulin receptor sub- 
unit in intact hepatocytes. Freshly isolated hepatocytes 
were incubated in 32Pi containing medium for 30 min at 
37°C. Thereafter, buffer (lane a,d), insulin (IO-’ M) 
(lane b,e) and EGF (5 x 10 -’ M) (lane c,f) were added 
for 5 min at 37°C. The reaction was stopped. Insulin 
receptors were solubilized, purified and subjected to 
precipitation with either normal serum (lane d-f) or 
serum containing autoantibodies to insulin-receptor 
(lane a-c) at a I:300 dilution as in [lo]. The immuno- 
precipitates were analyzed by SDS-PAGE under 
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is recognized as the j&subunit of the insulin receptor 
because: 
(i) Serum from a normal individual does not im- 
munoprecipitate labeled material with the 
same electrophorectic mobility (fig. 1); 
(ii) Precipitation of this band by antireceptor 
serum is decreased when the immunoprecipi- 
tation is preceded by exposure to insulin (not 
shown); 
(iii) Using biosynthetic labeling methods in hepa- 
tocytes and other cells we have identified a 
subunit of the insulin receptor with identical 
electrophoretic mobility [ 10,2 11. 
Insulin increased significantly the phosphoryl- 
ation of its receptor subunit (fig.1). Thus, quanti- 
tative analysis revealed typically a 30-50s stimu- 
lation of the labeling of the M, 95 000 receptor 
subunit. Note that insulin had no detectable effect 
on the 32Pi incorporation into total cellular proteins 
as measured by trichloroacetic acid precipitability. 
49- 
M,x10-3 
Fig.2. Phosphorylation of Mr 95 000 insulin receptor 
subunit in a cell-free system. Purified solubilized insulin 
receptors obtained from normal rat hepatocytes as in 
section 2, were incubated with [Y-~~P]ATP for 5 min at 
37°C in the absence (lane a,c) or presence of insulin 
(IO-’ M) (lane b,d), EGF (5 X IO-’ M) (lane e). The 
reaction was stopped. Labeled insulin receptors were 
immunoprecipitated with serum containing autoanti- 
bodies to receptor (lane c-e). In a control experiment a 
pool of normal sera was used (lane a,b). The precipitates 
were analyzed by SDS-PAGE under reducing 
conditions. An autoradiogram of a gel is shown. 
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insulin’s effect was even more pronounced in iso- 
lated receptors. Indeed, insulin increased 3-5-fold 
the incorporation of 32P label in the M, 95 000 re- 
ceptor subunit. In contrast, EGF was without effect 
indicating that insulin’s action on its receptor is 
specific (fig.2). 
4. DISCUSSION 
We have shown here that in intact normal rat 
hepatocytes insulin specifically increases the 
phosphorylation of its receptor subunit with M, 
95 000. This selective stimulating effect of insulin is 
preserved, and more importantly, is magnified 
several-fold in a cell-free system using solubilized 
insulin receptors. The remarkable efficiency of the 
insulin-stimulated phosphorylation reaction in a 
cell-free system suggests that the kinase activity is 
contained within the receptor, or that the receptor 
and kinase activity are in the same detergent micelle 
and therefore, are likely to be associated in the 
intact membrane. At present, the biological role of 
the insulin-enhanced phosphorylaton reaction of its 
own receptor is not known. However, it is tempting 
to speculate on its possible relationship to biologi- 
cally important processes such as transmembrane 
hormone signal transfer, hormone-receptor intern- 
alization, down-regulation of receptors. We believe 
that this novel demonstration of insulin receptor 
phosphorylation in a cell-free system opens a new 
avenue for investigating the biochemical regulation 
of the insulin-induced covalent modification of its 
receptor subunit, and for unraveling the role of 
receptor phosphorylation in biologically important 
phenomena. 
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